Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring

Arthritis Care and Research

Volumn 63, Issue 6, 2011, Pages 865-874

  Hsieh, Christine ^a   Chang, Anthony ^a   Brandt, Daniel ^a   Guttikonda, Riteesha ^a   Utset, Tammy O ^a   Clark, Marcus R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DOUBLE STRANDED DNA ANTIBODY;

ADULT; ARTICLE; CHRONICITY; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PREDICTION; PROGNOSIS; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; CICATRIX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LUPUS NEPHRITIS; MALE; NEPHRITIS, INTERSTITIAL; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79958781145     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20441     Document Type: Article

References (46)

1. Mok C, Tang SS. Incidence and predictors of renal disease in Chinese patients with systemic lupus erythematosus. Am J Med 2004;117:791-5. (Pubitemid 39482532)
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308. (Pubitemid 37229465)
3. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006;54:2550-7. (Pubitemid 44205016)
4. McLaughlin J, Bombardier C, Farewell VT, Gladman DD, Urowitz MB. Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum 1994;37:559-67.
5. Cook R, Gladman DD, Pericak D, Urowitz MB. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol 2000;27:1892-5. (Pubitemid 30670482)
6. Ginzler E, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005;353:2219-28. (Pubitemid 41697285)
7. Appel G, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 2009;20:1103-12.
8. Flanc R, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC. Treatment for lupus nephritis. Cochrane Database Syst Rev 2004;1:CD0002922.
9. Korbet S, Schwartz MM, Evans J, Lewis EJ. Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007;18:244-54. (Pubitemid 46070148)
10. Donadio JJ, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995;4:109-15.
11. Neumann K, Wallace DJ, Azen C, Nessim S, Fichman M, Metzger AL, et al. Lupus in the 1980s. III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995;25:47-55.
12. Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TA, Kullick ME, Klippel JH, et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 1983;75:382-91. (Pubitemid 13005770)
13. Appel G, Cohen DJ, Pirani CL, Meltzer JI, Estes D. Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med 1987;83:877-85. (Pubitemid 18098162)
14. Parichatikanond P, Francis ND, Malasit P, Laohapand T, Nimmannit S, Singchoovong L, et al. Lupus nephritis: clinicopathological study of 162 cases in Thailand. J Clin Pathol 1986;39:160-6. (Pubitemid 16144971)
15. Esdaile J, Levinton C, Federgreen W, Hayslett JP, Kashgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med 1989;72:779-833. (Pubitemid 19230673)
16. Williams W, Sargeant LA, Smilkle M, Smith R, Edwards H, Shah D. The outcome of lupus nephritis in Jamaican patients. Am J Med Sci 2007;334:426-30. (Pubitemid 350306461)
17. Schwartz M, Fennell JS, Lewis EJ. Pathologic changes in the renal tubule in systemic lupus erythematosus. Hum Pathol 1982;13:534-47. (Pubitemid 12078994)
18. Bohle A, Grund KE, Mackensen S, Tolon M. Correlations between renal interstitium and level of serum creatinine: morphometric investigations of biopsies in perimembranous glomerulonephritis. Virchows Arch A Pathol Anat Histol 1977;373:13-22.
19. Park M, D'Agati V, Appel GB, Pirani CL. Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. Nephron 1986;44:309-19. (Pubitemid 17178104)
20. Arce-Salinas C, Villa AR, Martinez-Rueda JO, Munoz L, Cardiel MH, Alocer-Varela J, et al. Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study. Lupus 1995;4:197-203.
21. Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 2010;77: 820-9.
22. Chang A, Henderson S, Liu N, Reddy R, Hsieh C, Utset T, et al. In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. J Immunol 2011;186:1849-60.
23. Steinmetz O, Velden J, Kneissler U, Marx M, Klein A, Helmchen U, et al. Analysis and classification of B cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int 2008;74: 448-57.
24. Hochberg M, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
25. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al, for the Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145:247-54. (Pubitemid 46768608)
26. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629-37.
27. O'Dell JR, Hays RC, Guggenheim SJ, Steigerwald JC. Tubulointerstitial renal disease in systemic lupus erythematosus. Arch Intern Med 1985;145:1996-9. (Pubitemid 16198398)
28. Hill GS, Delahousse M, Nochy D, Mandet C, Bariety J. Proteinuria and tubulointerstitial lesions in lupus nephritis. Kidney Int 2001;60:1893-903. (Pubitemid 32999995)
29. Hill GS, Delahousse M, Nochy D, Tomkiewicz E, Remy P, Mignon F, et al. A new morphologic index for the evaluation of renal biopsies in lupus nephritis. Kidney Int 2000;58: 1160-73.
30. Nossent H, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak TJ. Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients. Arthritis Rheum 1990;33:970-7. (Pubitemid 20226350)
31. Mori Y, Kishimoto N, Yamahara H, Kijima Y, Nose A, Uchiyama-Tanaka Y, et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis. Clin Exp Nephrol 2005;9:79-84. (Pubitemid 40576890)
32. Omokawa A, Wakul H, Okuyama S, Togashi M, Ohtani H, Komatsuda A, et al. Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus: phenotype of infiltrating cells. Clin Nephrol 2008;69:436-44. (Pubitemid 351803485)
33. Gur H, Kopolovic Y, Gross J. Chronic predominant interstitial nephritis in a patient with systemic lupus erythematosus: a follow up of three years and review of the literature. Ann Rheum Dis 1987;46:617-23. (Pubitemid 17137190)
34. Alexopoulos E, Seron D, Hartley RB, Cameron JS. Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990;37:100-9. (Pubitemid 20023773)
35. Caligaris-Cappio F, Bergui L, Tesio L, Ziano R, Camussi G. HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus. Clin Exp Immunol 1985;59:185-9. (Pubitemid 15197412)
36. D'Agati V, Appel GB, Estes D, Knowles DM 2nd, Pirani CL. Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. Kidney Int 1986;30: 573-81. (Pubitemid 16000803)
37. Castiglione A, Bucci A, Fellin G, d'Amico G, Atkins RC. The relationship of infiltrating renal leucocytes to disease activity in lupus and cryoglobulinaemic glomerulonephritis. Nephron 1988;50:14-23.
38. Boucher A, Droz D, Adafer E, Noel LH. Characterization of mononuclear cell subsets in renal cellular infiltrates. Kidney Int 1986;29:1043-9. (Pubitemid 16122576)
39. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol 2005;18:503-12. (Pubitemid 41824469)
40. Nath K. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20: 1-17.
41. Dooley M, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Kidney Int 1997;51:1188-95. (Pubitemid 27186545)
42. Kleinknecht D. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995;15:228-35.
43. Bakir A. The prognosis of lupus nephritis in African-Americans: a retrospective analysis. Am J Kidney Dis 1994; 24:159-71. (Pubitemid 24249053)
44. Lea J. Lupus nephritis in African Americans. Am J Med Sci 2002;323:85-9. (Pubitemid 34651559)
45. Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, et al. Outcomes in African Americans and Hispanics with lupus nephritis. Kidney Int 2006;69:1846-51. (Pubitemid 43739214)
46. Austin H, Boumpas DT, Vaughan EM, Balow JE. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994;45:544-50. (Pubitemid 24065091)